<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MEDI</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Wolters Kluwer Health</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28272252</article-id><article-id pub-id-type="pmc">5348200</article-id><article-id pub-id-type="publisher-id">MD-D-17-00771</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000006288</article-id><article-id pub-id-type="art-access-id">06288</article-id><article-categories><subj-group subj-group-type="heading"><subject>3300</subject></subj-group><subj-group><subject>Research Article</subject><subject>Clinical Trial/Experimental Study</subject></subj-group></article-categories><title-group><article-title>Comparative evaluation of the effect of remifentanil and 2 different doses of esmolol on pain during propofol injection</article-title><subtitle>A double-blind, randomized clinical consort study</subtitle></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Myunghwan</given-names></name><degrees>DDS</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kwon</surname><given-names>Taegeon</given-names></name><degrees>DDS</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Sujin</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Saeyoung</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Kibum</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jeon</surname><given-names>Younghoon</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref rid="cor1" ref-type="corresp"><sup>&#x02217;</sup></xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Hanaoka.</surname><given-names>Kazuo</given-names></name></contrib></contrib-group><aff id="aff1"><label>a</label>Department of Oral and Maxillofacial surgery, School of Dentistry</aff><aff id="aff2"><label>b</label>Department of Anesthesiology and Pain Medicine, Kyungpook National University Hospital</aff><aff id="aff3"><label>c</label>Department of Anesthesiology and Pain Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.</aff><author-notes id="cor1"><corresp><label>&#x02217;</label>Correspondence: Younghoon Jeon, Department of Oral and Maxillofacial Surgery, Department of Anesthesiology and Pain Medicine, School of Dentistry, Kyungpook National University, 130 Dongduck-ro, Jung-gu, Daegu 41944, Republic of Korea (e-mail: <email>jeon68@gmail.com</email>).</corresp></author-notes><pub-date pub-type="collection"><month>3</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>10</day><month>3</month><year>2017</year></pub-date><volume>96</volume><issue>10</issue><elocation-id>e6288</elocation-id><history><date date-type="received"><day>7</day><month>2</month><year>2017</year></date><date date-type="rev-recd"><day>9</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>13</day><month>2</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link></license-p></license></permissions><self-uri xlink:type="simple" xlink:href="medi-96-e6288.pdf"/><abstract><title>Abstract</title><sec sec-type="background"><title>Background:</title><p>Propofol is associated with pain during injection, which is stressful to patients. The present study was designed to investigate the analgesic effect of pretreatment with remifentanil and esmolol in minimizing propofol injection pain, compared with placebo.</p></sec><sec sec-type="methods"><title>Methods:</title><p>In a randomized, double-blind, prospective trial, 120 patients, scheduled for elective dental surgery under general anesthesia, were randomized to 1 of the 4 treatment arms (n&#x0200a;=&#x0200a;30 each) receiving normal saline, remifentanil 0.35&#x0200a;&#x003bc;g/kg, esmolol 0.5&#x0200a;mg/kg, and 1&#x0200a;mg/kg before administration of propofol. During injection of 1% propofol 0.5&#x0200a;mg/kg, pain was evaluated by a 4-point score (0&#x0200a;=&#x0200a;none, 1&#x0200a;=&#x0200a;mild, 2&#x0200a;=&#x0200a;moderate, 3&#x0200a;=&#x0200a;severe). Any adverse effects such as hypotension and bradycardia were recorded during the perioperative periods.</p></sec><sec sec-type="results"><title>Results:</title><p>In all, 120 patients completed this study. There were no significant differences in terms of demographic data. The incidence of pain on injection of propofol was 11 (36.7%) with remifentanil 0.35&#x0200a;&#x003bc;g/kg, 12 (40%) with esmolol 0.5&#x0200a;mg/kg, and 11 (36.7%) with esmolol 1&#x0200a;mg/kg, compared with 25 (83.3%) with normal saline (respectively, <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;0.05). There were no significant differences in the incidence of pain between groups with remifentanil 0.35&#x0200a;&#x003bc;g/kg, and esmolol 0.5&#x0200a;mg/kg and 1&#x0200a;mg/kg. There were no emergence reactions such as hypotension and bradycardia in all groups.</p></sec><sec sec-type="conclusion"><title>Conclusions:</title><p>Pretreatment with esmolol 0.5&#x0200a;mg/kg and 1&#x0200a;mg/kg and remifentanil 0.35&#x0200a;&#x003bc;g/kg equally decreased pain during propofol injection.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>esmolol</kwd><kwd>injection</kwd><kwd>intravenous</kwd><kwd>pain</kwd><kwd>propofol</kwd><kwd>remifentanil</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><label>1</label><title>Introduction</title><p>Propofol is a short-acting intravenous hypnotic agent, which is widely used for sedation and general anesthesia. However, pain during injection of propofol can occur in up to 80% of patients, which can be very stressful to patients.<sup>[<xref rid="R1" ref-type="bibr">1</xref>&#x02013;<xref rid="R3" ref-type="bibr">3</xref>]</sup> Many methods including cooling or diluting the propofol solution or the concomitant use of drugs such as methylene blue, pregabalin, or magnesium sulfate have been used to reduce this pain.<sup>[<xref rid="R1" ref-type="bibr">1</xref>&#x02013;<xref rid="R3" ref-type="bibr">3</xref>]</sup> However, these treatments cannot alleviate the pain, which remains a challenge. It was reported that aqueous free propofol could be responsible for injection pain. Therefore, propofol long-chain triglycerides (LCTs)/medium-chain triglycerides (MCTs) were introduced to minimize injection pain, which has less concentration of aqueous free propofol than propofol-LCT.<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup> This new formulation of propofol is more expensive than standard propofol. However, pain on injection still occurs despite use of propofol-LCT/MCT.<sup>[<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref>]</sup></p><p>Remifentanil is a potent, short-acting intravenous opioid. Pretreatment with small dose of remifentanil has been demonstrated to be effective in reducing pain from propofol injection without side effects.<sup>[<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref>]</sup> Esmolol, a short-acting &#x003b2;1 adrenergic receptor antagonist, is widely used to reduce cardiovascular stress response to layngoscopy and tracheal intubation.<sup>[<xref rid="R9" ref-type="bibr">9</xref>&#x02013;<xref rid="R11" ref-type="bibr">11</xref>]</sup> It was shown that perioperative infusion of esmolol reduced anesthetic requirement for surgery <sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup> and postoperative analgesic consumption.<sup>[<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref>]</sup> Recently, it was reported that pretreatment with esmolol 0.5&#x0200a;mg/kg has analgesic effect on rocuronium injection pain without side effects.<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup></p><p>The present study was designed to compare the analgesic effect of pretreatment with remifentanil 0.35&#x0200a;&#x003bc;g/kg, and esmolol 0.5&#x0200a;mg/kg and 1&#x0200a;mg/kg in minimizing pain during injection of propofol-LCT, compared with placebo.</p></sec><sec><label>2</label><title>Methods</title><sec><label>2.1</label><title>Patients and exclusion criteria</title><p>In all, 120 patients aged 18 to 70 years, American Society of Anesthesiologists physical status I and II, scheduled for elective dental surgery requiring general anesthesia were included. We excluded patients who have cardiac, neurologic or psychiatric problem, patients who had analgesic or sedative agents within 24&#x0200a;hours before surgery, and patients requiring a rapid sequence induction.</p></sec><sec><label>2.2</label><title>Anesthesia and data collection</title><p>The present study was approved by the Ethics Committee of Kyungpook National University Hospital (KNUH 2013&#x02013;05&#x02013;003&#x02013;001) and informed written consent was obtained from all patients. This study was registered in the ClinicalTrials.GOV (NCT01885364). Premedication was not given. On arrival in the operating room, electrocardiogram, noninvasive blood pressure, and pulse oximetry were measured, and a 22-gauge catheter was inserted into a dorsal vein of the patient's nondominant hand. Using a computer-generated table, patients were randomized to 1 of the 4 treatment arms (n&#x0200a;=&#x0200a;30 each) receiving normal saline, remifentanil 0.35&#x0200a;&#x003bc;g/kg, esmolol 0.5&#x0200a;mg/kg and 1&#x0200a;mg/kg as pretreatment. A study-blinded nurse prepared pretreatment substance using identically coded syringes at room temperature.</p><p>Pretreatment substances were injected over 10&#x0200a;seconds. Thirty seconds after injection of pretreatment drug, patients received propofol-LCT 0.5&#x0200a;mg/kg at rate of 0.5&#x0200a;mL/sec using syringe pump. A study-blinded anesthesiologist measured score of injection pain of propofol using a 4-point scale (0&#x0200a;=&#x0200a;none [negative response to questioning], 1&#x0200a;=&#x0200a;mild pain [pain reported in response to questioning only, without any behavioral sign], 2&#x0200a;=&#x0200a;moderate pain [pain reported in response to questioning and accompanied by a behavioral sign, or pain reported simultaneously without questioning], 3&#x0200a;=&#x0200a;severe pain [strong vocal response or response accompanied by facial grimacing, arm withdrawal or tears]).<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> Thereafter, propofol-LCT1.5&#x0200a;mg/kg and rocuronium 0.8&#x0200a;mg/kg were administered for tracheal intubation, and anesthesia was maintained with desflurane 4% to 7% in 50% N<sub>2</sub>O/O<sub>2</sub>. Emergence reactions associated with pretreatment substances such as hypotension and bradycardia were recorded. In the present study, the incidence and severity of pain after propofol injection was the primary outcome, and all other variables were secondary outcomes.</p></sec><sec><label>2.3</label><title>Sample size</title><p>On the basis of previously published data,<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> we estimated the incidence of pain during propofol injection in the placebo group to be around 80%. A 40% difference (80%&#x02013;40%) between placebo group and treatment groups would be considered of clinical significance. Using a 2-tailed test of the proportions with &#x003b1; error of 0.05 and &#x003b2; error of 0.8, 30 patients per group were required to detect such difference.</p></sec><sec><label>2.4</label><title>Statistical analysis</title><p>Data were analyzed using statistical software (SPSS, version 23.0 for Windows; SPSS, Chicago, IL). The factorial analysis of variance was used for age and weight. Fisher exact test or the chi-square test was used for sex, incidence of pain, and incidence of side effects. <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;0.05 was considered to indicate statistical significance. SPSS (version 16.0) was used for statistical analysis.</p></sec></sec><sec><label>3</label><title>Results</title><p>In all, 120 patients completed the study (Fig. <xref ref-type="fig" rid="F1">1</xref>). There was no difference in demographic data between groups (Table <xref ref-type="table" rid="T1">1</xref>). The overall incidence of pain after propofol injection is demonstrated in Table <xref ref-type="table" rid="T2">2</xref>. The incidence of pain during propofol injection was significantly reduced with remifentanil 0.35&#x0200a;&#x003bc;g/kg (36.7%), esmolol 0.5&#x0200a;mg/kg (40%) and 1&#x0200a;mg/kg (36.7%), compared with placebo group (83.3%) (respectively, <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;0.05). In addition, pretreatment with remifentanil (3.3%), and esmolol 0.5&#x0200a;mg/kg (3.3%) and 1&#x0200a;mg/kg (3.3%) significantly decreased the incidence of severe injection pain, compared with placebo (26.7%) (respectively, <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;0.05). There were no emergence reactions associated with pretreatment substances such as hypotension and bradycardia in all groups.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Flow diagram of the study.</p></caption><graphic xlink:href="medi-96-e6288-g001"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic characteristics of the study population (n&#x0200a;=&#x0200a;120).</p></caption><graphic xlink:href="medi-96-e6288-g002"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Incidence and pain severity during injection of propofol.</p></caption><graphic xlink:href="medi-96-e6288-g003"/></table-wrap></sec><sec><label>4</label><title>Discussion</title><p>This study showed that pretreatment with remifentanil 0.35&#x0200a;&#x003bc;g/kg, and esmolol 0.5&#x0200a;mg/kg and 1&#x0200a;mg/kg, was equally effective to reduce pain during propofol injection, compared with placebo.</p><p>Propofol formulated in a lipid emulsion is widely used in various clinical procedures. But propofol is associated with high incidence of pain at injection site, which is often very stressful to patients.<sup>[<xref rid="R1" ref-type="bibr">1</xref>&#x02013;<xref rid="R3" ref-type="bibr">3</xref>]</sup> The exact mechanism of pain on propofol injection is unknown. The direct exposure of nociceptive receptors or free nerve ending in the vein by free propofol can increase the pain on injection.<sup>[<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R17" ref-type="bibr">17</xref>]</sup> Propofol-LCT/MCT was specially proposed to decrease injection pain. Varghese et al<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup> reported that when added with lidocaine, both propofol-LCT/MCT and propofol-LCT had similar incidence of injection pain. By a systemic review and meta-analysis in 2011, pretreatment with a small dose of opioids halved the incidence of pain after propofol injection, which can generally be recommended.<sup>[<xref rid="R19" ref-type="bibr">19</xref>]</sup> The previous study demonstrated that pretreatment with remifentanil 0.35&#x0200a;&#x003bc;g/kg reduced injection pain of propofol by 38.8% without any side effects.<sup>[<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R19" ref-type="bibr">19</xref>]</sup> In the present study, the incidence of pain from propofol injection was 33.3% in the patients who received remifentanil 0.35&#x0200a;&#x003bc;g/kg, which is consistent with the previous study.<sup>[<xref rid="R8" ref-type="bibr">8</xref>]</sup></p><p>Esmolol, antagonist of &#x003b2;1 adrenergic receptor, is often used to blunt adrenergic response to perioperative stimuli.<sup>[<xref rid="R10" ref-type="bibr">10</xref>&#x02013;<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R20" ref-type="bibr">20</xref>]</sup> It was demonstrated that a single injection of esmolol 1 to 2&#x0200a;mg/kg is effective to attenuate the increase of heart rate after intubation without adverse effects.<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup> In the previous studies, intraoperative infusion of esmolol decreased the requirement of opioid and inhalation anesthetic without causing hemodynamic change,<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup> and reduced postoperative analgesic consumption.<sup>[<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref>]</sup> Up to date, the exact analgesic mechanism of &#x003b2; adrenergic receptor antagonist remains unclear. Adrenal hormone, commonly known as stress hormone, increases during emotional distress and anxiety, which are associated with activation of hypocampal neurons.<sup>[<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R22" ref-type="bibr">22</xref>]</sup> &#x003b2; adrenergic receptors are involved in learning-facilitated plasticity in the mammalian hippocampus, which requires activation of N-methyl-d-aspartate (NMDA) receptor.<sup>[<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R24" ref-type="bibr">24</xref>]</sup> The activation of NMDA receptor in the hippocampus is involved in nociceptive processing, at least, in part. Therefore, esmolol with lipophilic property can decrease adrenergic activity in the hippocampus.<sup>[<xref rid="R25" ref-type="bibr">25</xref>]</sup> In addition, it was found that esmolol can facilitate inhibitory transmitter release in spinal trigeminal nucleus, which produces analgesic effects.<sup>[<xref rid="R26" ref-type="bibr">26</xref>]</sup> In the present study, pretreatment with esmolol 0.5&#x0200a;mg/kg and 1&#x0200a;mg/kg and remifentanil 0.35&#x0200a;&#x003bc;g/kg equally decreased pain during propofol injection.</p><p>The incidence of pain when propofol was injected into vein of the dorsum of hand can reach as high as 80%.<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R19" ref-type="bibr">19</xref>]</sup> Therefore, it was considered unethical to use placebo in this study. Pretreatment substances such as remifentanil and esmolol can cause dose-dependent decrease in blood pressure and heart rate. Therefore, a placebo group was included to investigate the adverse effect of the pretreatment substances. In the present study, there were no emergence reactions associated with pretreatment with remifentanil 0.35&#x0200a;&#x003bc;g/kg, and esmolol 0.5&#x0200a;mg/kg and 1&#x0200a;mg/kg. These results were compatible with the previous studies.<sup>[<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R10" ref-type="bibr">10</xref>]</sup></p><p>The present study had some limitations. In the present study, premedication, such as sedatives, was not given. This might increase the patient's anxiety and dissatisfaction about anesthetic care.<sup>[<xref rid="R27" ref-type="bibr">27</xref>]</sup> The previous study showed that 87% of patients who did not receive anxiolytic premedication reported the recall about injection pain after propofol injection.<sup>[<xref rid="R28" ref-type="bibr">28</xref>]</sup> Therefore, another study is needed to examine the patient's satisfaction about anesthetic care and the incidence of recall for pain during propofol injection.</p></sec><sec><label>5</label><title>Conclusions</title><p>In conclusion, pretreatment with esmolol 0.5&#x0200a;mg/kg and 1&#x0200a;mg/kg, and remifentanil 0.35&#x0200a;&#x003bc;g/kg were equally effective in reducing pain during injection of propofol without adverse effects.</p></sec></body><back><fn-group><fn fn-type="abbr"><p>Abbreviations: LCT = long-chain triglyceride, MCT = medium-chain triglyceride, NMDA = N-methyl-d-aspartate.</p></fn><fn fn-type="COI-statement"><p>The authors have no competing interests to disclose.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salman</surname><given-names>AE</given-names></name><name><surname>Salman</surname><given-names>MA</given-names></name><name><surname>Saricaoglu</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Pain on injection of propofol: a comparison of methylene blue and lidocaine</article-title>. <source>J Clin Anesth</source>
<year>2011</year>;<volume>23</volume>:<fpage>270</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">21663809</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Jeon</surname><given-names>Y</given-names></name></person-group>
<article-title>Comparative study between 2 different doses of pregabalin and lidocaine on pain following propofol injection: a double-blind, randomized clinical consort study</article-title>. <source>Medicine (Baltimore)</source>
<year>2016</year>;<volume>95</volume>:<fpage>e5153</fpage>.<pub-id pub-id-type="pmid">28002316</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group>
<article-title>Effects and safety of magnesium sulfate on propofol-induced injection pain, a meta-analysis of randomized controlled trials</article-title>. <source>Int J Clin Exp Med</source>
<year>2015</year>;<volume>15</volume>:<fpage>6813</fpage>&#x02013;<lpage>21</lpage>.</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doenicke</surname><given-names>AW</given-names></name><name><surname>Roizen</surname><given-names>MF</given-names></name><name><surname>Rau</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Pharmacokinetics and pharmacodynamics of propofol in a new solvent</article-title>. <source>Anesth Analg</source>
<year>1997</year>;<volume>85</volume>:<fpage>1399</fpage>&#x02013;<lpage>403</lpage>.<pub-id pub-id-type="pmid">9390616</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaub</surname><given-names>E</given-names></name><name><surname>Kern</surname><given-names>C</given-names></name><name><surname>Landau</surname><given-names>R</given-names></name></person-group>
<article-title>Pain on injection: a double-blind comparison of propofol with lidocaine pretreatemt versus propofol formulated with long-and medium-chain triglycerides</article-title>. <source>Anesth Analg</source>
<year>2004</year>;<volume>99</volume>:<fpage>1699</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="pmid">15562057</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krobbuaban</surname><given-names>B</given-names></name><name><surname>Siriwan</surname><given-names>D</given-names></name><name><surname>Kumkeaw</surname><given-names>S</given-names></name></person-group>
<article-title>Does addition of lidocaine to medium- and long-chain triglyceride propofol emulsions significantly reduce pain on injection?</article-title>
<source>J Med Assoc Thai</source>
<year>2008</year>;<volume>91</volume>:<fpage>383</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">18575293</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyilikci</surname><given-names>L</given-names></name><name><surname>Balkan</surname><given-names>BK</given-names></name><name><surname>Gokel</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>The effects of alfentanil or remifentanil pretreatment on propofol injection pain</article-title>. <source>J Clin Anesth</source>
<year>2004</year>;<volume>16</volume>:<fpage>499</fpage>&#x02013;<lpage>502</lpage>.<pub-id pub-id-type="pmid">15590252</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Reduction of pain on injection of propofol: combination of pretreatment of remifentanil and premixture of lidocaine with propofol</article-title>. <source>Eur J Anaesthesiol</source>
<year>2007</year>;<volume>24</volume>:<fpage>746</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">17261216</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Galinski</surname><given-names>S</given-names></name><name><surname>Bermejo</surname><given-names>S</given-names></name><name><surname>Mansilla</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Comparative assessment of the effects of alfentanil, esmolol or clonidine when used as adjuvants during induction of general anaesthesia</article-title>. <source>Eur J Anaesthesiol</source>
<year>2004</year>;<volume>21</volume>:<fpage>476</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">15248628</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kindler</surname><given-names>CH</given-names></name><name><surname>Schumacher</surname><given-names>PG</given-names></name><name><surname>Schneider</surname><given-names>MC</given-names></name><etal/></person-group>
<article-title>Effects of intravenous lidocaine and/or esmolol on hemodynamic responses to laryngoscopy and intubation: a double-blind, controlled clinical trial</article-title>. <source>J Clin Anesth</source>
<year>1996</year>;<volume>8</volume>:<fpage>491</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">8872690</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menigaux</surname><given-names>C</given-names></name><name><surname>Guignard</surname><given-names>B</given-names></name><name><surname>Adam</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Esmolol prevents movement and attenuates the BIS response to orotracheal intubation</article-title>. <source>Br J Anaesth</source>
<year>2002</year>;<volume>89</volume>:<fpage>857</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">12453930</pub-id></mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname><given-names>JW</given-names></name><name><surname>Schneider</surname><given-names>G</given-names></name><name><surname>Windsor</surname><given-names>AM</given-names></name><etal/></person-group>
<article-title>Esmolol potentiates reduction of minimum alveolar isoflurane concentration by alfentanil</article-title>. <source>Anesth Analg</source>
<year>1998</year>;<volume>87</volume>:<fpage>671</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">9728851</pub-id></mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chia</surname><given-names>YY</given-names></name><name><surname>Chan</surname><given-names>MH</given-names></name><name><surname>Ko</surname><given-names>NH</given-names></name><etal/></person-group>
<article-title>Role of beta-blockade in anaesthesia and postoperative pain management after hysterectomy</article-title>. <source>Br J Anaesth</source>
<year>2004</year>;<volume>93</volume>:<fpage>799</fpage>&#x02013;<lpage>805</lpage>.<pub-id pub-id-type="pmid">15377583</pub-id></mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haghighi</surname><given-names>M</given-names></name><name><surname>Sedighinejad</surname><given-names>A</given-names></name><name><surname>Mirbolook</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Effect of intravenous intraoperative esmolol on pain management following lower limb orthopedic surgery</article-title>. <source>Korean J Pain</source>
<year>2015</year>;<volume>28</volume>:<fpage>198</fpage>&#x02013;<lpage>202</lpage>.<pub-id pub-id-type="pmid">26175880</pub-id></mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yavascaoglu</surname><given-names>B</given-names></name><name><surname>Kaya</surname><given-names>FN</given-names></name><name><surname>Ozcan</surname><given-names>B</given-names></name></person-group>
<article-title>Esmolol pretreatment reduces the frequency and severity of pain on injection of rocuronium</article-title>. <source>J Clin Anesth</source>
<year>2007</year>;<volume>19</volume>:<fpage>413</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">17967668</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwama</surname><given-names>H</given-names></name><name><surname>Nakane</surname><given-names>M</given-names></name><name><surname>Ohmori</surname><given-names>S</given-names></name></person-group>
<article-title>Nafamostat mesilate, a kallikrein inhibitor, prevents pain on injection with propofol</article-title>. <source>Br J Anaesth</source>
<year>1998</year>;<volume>81</volume>:<fpage>963</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">10211027</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Chae</surname><given-names>YJ</given-names></name><name><surname>Chang</surname><given-names>HS</given-names></name><etal/></person-group>
<article-title>Intravenous lidocaine pretreatment with venous occlusion for reducing microemulsion propofol induced pain: comparison of three doses of lidocaine</article-title>. <source>J Int Med Res</source>
<year>2014</year>;<volume>42</volume>:<fpage>368</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">24595146</pub-id></mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varghese</surname><given-names>E</given-names></name><name><surname>Krishna</surname><given-names>HM</given-names></name><name><surname>Nittala</surname><given-names>A</given-names></name></person-group>
<article-title>Does the newer preparation of propofol, an emulskon of medium/long chain trigrlycerides cause less injection pain in children when premixed with lignocaine?</article-title>
<source>Paediatr Anaesth</source>
<year>2010</year>;<volume>20</volume>:<fpage>338</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">20470337</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalota</surname><given-names>L</given-names></name><name><surname>Kalira</surname><given-names>V</given-names></name><name><surname>George</surname><given-names>E</given-names></name></person-group>
<article-title>Prevention of pain on injection of propofol: systematic review and meta-analysis</article-title>. <source>BMJ</source>
<year>2011</year>;<volume>342</volume>:<fpage>d1110</fpage>.<pub-id pub-id-type="pmid">21406529</pub-id></mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozturk</surname><given-names>T</given-names></name><name><surname>Kaya</surname><given-names>H</given-names></name><name><surname>Aran</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Postoperative beneficial effects of esmolol in treated hypertensive patients undergoing laparoscopic cholecystectomy</article-title>. <source>Br J Anaesth</source>
<year>2008</year>;<volume>100</volume>:<fpage>211</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">18037672</pub-id></mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Lacadie</surname><given-names>C</given-names></name><name><surname>Skudlarski</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Neural circuits underlying emotional distress in humans</article-title>. <source>Ann N Y Acad Sci</source>
<year>2004</year>;<volume>1032</volume>:<fpage>254</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">15677422</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surguladze</surname><given-names>SA</given-names></name><name><surname>Brammer</surname><given-names>MJ</given-names></name><name><surname>Young</surname><given-names>AW</given-names></name><etal/></person-group>
<article-title>A preferential increase in the extrastriate response to signals of danger</article-title>. <source>NeuroImage</source>
<year>2003</year>;<volume>19</volume>:<fpage>1317</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">12948690</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>N</given-names></name><name><surname>Manahan-Vaughan</surname><given-names>D</given-names></name></person-group>
<article-title>Hippocampal long-term potentiation that is elicited by perforant path stimulation or that occurs in conjunction with spatial learning is tightly controlled by beta-adrenoreceptors and the locus coeruleus</article-title>. <source>Hippocampus</source>
<year>2015</year>;<volume>25</volume>:<fpage>1285</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">25727388</pub-id></mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>JF</given-names></name><name><surname>Jackson</surname><given-names>MF</given-names></name><name><surname>Beazely</surname><given-names>MA</given-names></name></person-group>
<article-title>Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors</article-title>. <source>Crit Rev Neurobiol</source>
<year>2006</year>;<volume>18</volume>:<fpage>71</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">17725510</pub-id></mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorczynski</surname><given-names>RJ</given-names></name><name><surname>Shaffer</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>RJ</given-names></name></person-group>
<article-title>Pharmacology of ASL-8052, a novel beta-adrenergic receptor antagonist with an ultrashort duration of action</article-title>. <source>J Cardiovasc Pharmacol</source>
<year>1983</year>;<volume>5</volume>:<fpage>668</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">6193366</pub-id></mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasui</surname><given-names>Y</given-names></name><name><surname>Masaki</surname><given-names>E</given-names></name><name><surname>Kato</surname><given-names>F</given-names></name></person-group>
<article-title>Esmolol modulates inhibitory neurotransmission in the substantia gelatinosa of the spinal trigeminal nucleus of the rat</article-title>. <source>BMC Anesthesiol</source>
<year>2011</year>;<volume>11</volume>:<fpage>15</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">21888677</pub-id></mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>YM</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name></person-group>
<article-title>Etifoxine for pain patients with anxiety</article-title>. <source>Korean J Pain</source>
<year>2015</year>;<volume>28</volume>:<fpage>4</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">25589941</pub-id></mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>JE</given-names></name><name><surname>Seavell</surname><given-names>CR</given-names></name><name><surname>Bowen</surname><given-names>DJ</given-names></name></person-group>
<article-title>Pretreatment with alfentanil reduces pain caused by propofol</article-title>. <source>Br J Anaesth</source>
<year>1994</year>;<volume>72</volume>:<fpage>342</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">8130055</pub-id></mixed-citation></ref></ref-list></back></article>